![Bryan Stuart](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Bryan Stuart
Directeur Général chez
Atavistik Bio, Inc.
Profil
Bryan E.
Stuart currently works at Atavistik Bio, Inc., as Chief Executive Officer & Director from 2023.
Mr. Stuart also formerly worked at Kastle Therapeutics LLC, as President & Chief Executive Officer in 2017, Fulcrum Therapeutics, Inc., as President, Chief Executive Officer & Director from 2022 to 2023, Yarra Therapeutics LLC, as President & Chief Executive Officer from 2017 to 2018, EKR Therapeutics, Inc., as Chief Corporate Development Officer from 2011 to 2012, OVATION Pharmaceuticals, Inc., as VP-Corporate Development, Merger & Acquisitions from 2001 to 2010, and Civitas Therapeutics, Inc., as Chief Business Officer from 2012 to 2014.
Mr. Stuart received his undergraduate degree from the University of Illinois and Masters Business Admin degree from Kellogg School of Management.
Postes actifs de Bryan Stuart
| Sociétés | Poste | Début |
|---|---|---|
Atavistik Bio, Inc.
 Atavistik Bio, Inc. BiotechnologyHealth Technology Develops precision allosteric therapeutics | Directeur Général | 17/07/2023 |
Anciens postes connus de Bryan Stuart
| Sociétés | Poste | Fin |
|---|---|---|
| FULCRUM THERAPEUTICS, INC. | Directeur Général | 02/01/2023 |
Yarra Therapeutics LLC | Directeur Général | 01/08/2018 |
Kastle Therapeutics LLC
 Kastle Therapeutics LLC Medical/Nursing ServicesHealth Services Develops therapeutics targeted towards patients with high unmet medical needs | Directeur Général | 01/11/2017 |
Civitas Therapeutics, Inc.
 Civitas Therapeutics, Inc. BiotechnologyHealth Technology Develops transformative pulmonary delivery therapies | Corporate Officer/Principal | 01/10/2014 |
EKR Therapeutics, Inc.
 EKR Therapeutics, Inc. Hospital/Nursing ManagementHealth Services Provides prescription products and oncology supportive care solutions | Corporate Officer/Principal | 01/06/2012 |
Formation de Bryan Stuart
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
33
Relations au 1er degré
9
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
EKR Therapeutics, Inc.
EKR Therapeutics, Inc. Hospital/Nursing ManagementHealth Services Provides prescription products and oncology supportive care solutions | Health Services |
University of Illinois
 University of Illinois Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
OVATION Pharmaceuticals, Inc.
 OVATION Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets pharmaceuticals | Health Technology |
Civitas Therapeutics, Inc.
Civitas Therapeutics, Inc. BiotechnologyHealth Technology Develops transformative pulmonary delivery therapies | Health Technology |
Kellogg School of Management
 Kellogg School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kastle Therapeutics LLC
Kastle Therapeutics LLC Medical/Nursing ServicesHealth Services Develops therapeutics targeted towards patients with high unmet medical needs | Health Services |
Fulcrum Therapeutics, Inc.
 Fulcrum Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops medicines for patients by transforming gene regulation in disease | Health Technology |
Yarra Therapeutics LLC | |
Atavistik Bio, Inc.
Atavistik Bio, Inc. BiotechnologyHealth Technology Develops precision allosteric therapeutics | Health Technology |
Choisissez Zonebourse 
